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Web appendix 
 
Appendix 1: Detailed justification for state transition parameters in the model 
 
Time from onset of symptoms to treatment with and without Find and Treat 
 
To assess the impact of the mobile screening unit, both mobile unit-screened cases and 
passively presenting controls from the retrospective cohort were divided into three groups: (i) 
asymptomatic on presentation, (ii) diagnostic delay of up to 131 days, and (iii) diagnostic 
delay of greater than 131 days. The cut-off of 131 days was used to separate cases that were 
exceedingly unlikely to present passively from those with shorter delays. The value of 131 
days was based on the upper limit of the interquartile range of delays to start of treatment 
(median 67 days, lower limit 30 days) in a study of the effect of socio-economic deprivation 
on tuberculosis treatment delays in England in 2000-2005
1
. 
 
Exponential curves (representing models with a constant probability of diagnosis per patient 
per unit time) were fitted to the proportion of patients still untreated by time since onset of 
symptoms. Data were aggregated into categories of 10 days length for this purpose. A good 
fit was found to data from all passively presenting controls, as well as to mobile screening 
unit cases with delays of up to 131 days (Figure A1-1). A separate exponential curve with a 
shallower slope fitted the diagnostic delay for mobile screening unit cases with delays of 
greater than 131 days. 
 
Figure A1-1. Time between onset of symptoms and diagnostic confirmation for mobile 
screening unit and passively presenting cases (shown as the proportion diagnosed within 
categories of size 10 days; excludes cases asymptomatic on presentation), as well as best 
fitting exponential curves. 
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The mobile screening unit population has shorter delays than those in the passively 
presenting population (median 29 days for mobile screening unit and 48 days for passively 
presenting cases). However, if cases presenting asymptomatically are excluded, the mobile 
screening unit population has longer delays. This is likely to represent the exceedingly hard-
to-reach nature of those who present via the mobile screening unit, rather than passively. 
Although passive controls were chosen for having risk factors, they were by definition cases 
who presented for treatment, while the mobile screening unit is likely to be reaching cases 
who would otherwise never present. 
 
Based on these fits, patients were modelled in the following way: 
 
(i) Symptomatic cases with diagnostic delays of up to 131 days. The proportion of cases 
diagnosed within a year in this group was extremely high for both passively presenting 
and mobile screening unit cases (one year rate of diagnosis of 99% in passively 
presenting cases and 98% in mobile screening unit cases). Hence the difference 
between passively presenting and mobile screening unit cases in this category was 
assumed to be negligible.  
 
(ii) Mobile screening unit cases with diagnostic delay greater than 131 days. 22.9% of 
mobile screening unit cases had a delay of more than 131 days. These were assumed to 
otherwise not present for treatment without the activities of the Find and Treat service. 
The time between symptom onset and mobile screening unit screening was not 
considered, since the health state of the cases (untreated active tuberculosis) is exactly 
the same during that time period, whether or not the mobile screening unit exists. 
 
(iii) Asymptomatic cases with active tuberculosis. 35.4% of mobile screening unit cases 
were asymptomatic on detection, but none of the passively presenting cases. Data from 
repeated radiological examination of populations suggest that individuals with positive 
chest radiograph changes progress rapidly to active symptomatic tuberculosis
2
. Hence it 
was assumed that all these cases would eventually progress to symptomatic disease, and 
that the time for this to occur was negligible for the purposes of discounting. Upon 
onset of symptoms, it was assumed that this group would behave in the same way as 
symptomatic cases in the absence of Find and Treat, i.e. that the majority would present 
for treatment almost immediately while 35.4% [= 22.9% out of (100 – 35.4%)] would 
not present without Find and Treat involvement. 
 
Clinical outcomes of cases with active tuberculosis detected by the mobile screening unit 
 
Mobile screening unit cases were divided into four groups based on their status on 30 
September 2010: (i) still on treatment, (ii) completed treatment, (iii) lost to follow up 
(including patients who stopped treatment due to poor adherence) and (iv) any other final 
outcome (patients who were transferred out of London, stopped treatment for clinical reasons 
or died of non-tuberculosis causes). Outcomes were based on London tuberculosis 
surveillance case records (Enhanced TB Surveillance), or from Find and Treat records 
instead, where these were missing. Three cases had missing dates of outcome in the London 
tuberculosis surveillance database (two who were recorded as having completed treatment, 
one who died of non-tuberculosis-related causes); their times to the outcomes were estimated 
using simple mean imputation from other cases in the same category. One patient whose date 
of treatment completion preceded the date of mobile screening unit screening was dropped 
from the dataset, so the 47 remaining patients were included in the analysis.  
 
An exponential model was fitted to the proportion of cases who were still on treatment, had 
completed treatment, were lost to follow up and had any other final outcome, by time since 
their initial mobile screening unit screen (aggregated into 50-day categories). Cases who were 
still on treatment at the end of their follow up time were distributed proportionately among 
the four remaining categories, since their actual time to treatment completion was unknown. 
The model fitted data well (see Figure 7) apart from data on the first few months after the 
initial screen. Hence a second model was fitted to the same data but with the assumption that 
cases would have a 125 day interval before they could complete treatment. The 125 day 
interval was based on actual treatment length in the identified cases and produced a good fit 
to data. A delay was not incorporated into the transition to being lost to follow up or other 
outcomes, since there did not appear to be any a priori reason for such a delay. 
 
Figure A1-2 shows the best fitting models to data. For the best fitting model without a 125 
day interval, the annual rate of completing treatment, being lost to follow up and having a 
different outcome are 50%, 1% and 8% respectively. For the best fitting model with a 125 
day interval, the corresponding rates are 54.6%, 67.1%, 2.1% and 10.1% for the annual rate 
of completing treatment in the first year, completing treatment in subsequent years, being lost 
to follow up and having other outcomes. 
 
Figure A1-2. Outcomes of 48 mobile screening unit-screened tuberculosis cases by days 
of follow up since the initial screen, and best fitting models to the data. Model 2 
incorporates a 125 day interval before cases move from being on treatment to another 
category, while Model 1 does not. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 200 400 600 800 1000
P
ro
p
o
rt
io
n
 o
f 
ca
se
s 
(%
)
Days since MXU screen
Data:  Under treatment
Data:  Completed treatment
Data:  LFU
Data:  Other outcome
Model 1:  Under treatment
Model 1:  Completed treatment
Model 1:  LFU
Model 1:  Other outcome
Model 2:  Under treatment
Model 2:  Completed treatment
Model 2:  LFU
Model 2:  Other outcome
  
Probability of being lost to follow up and re-engagement in the absence of Find and Treat 
 
The risk of being lost to follow up on treatment in the absence of Find and Treat were 
estimated from a cohort study of tuberculosis cases in Greater London in 2003/4, which 
found 321 prisoners, homeless and problem drug users out of the cohort of 1941 cases
3
. In 
this subgroup of cases most similar to the target group for Find and Treat, 9% were lost to 
follow up within 6 months of starting treatment. Assuming a constant risk of loss to follow 
up, this translates to a 17.2% risk in the absence of Find and Treat. It was assumed such cases 
have proportionately lower annual rates of completing treatment and „miscellaneous‟ 
outcomes, but the same rates of tuberculosis-related death. 
 
The rate at which cases lost to follow up re-engage with health services without Find and 
Treat involvement was estimated based on the outcomes of cases in London tuberculosis 
surveillance records from January 2004 to December 2005, a time period which pre-dates 
Find and Treat by more than a year. For those cases who were lost to follow up at one year, 
we looked for further episodes or notifications as indications that the cases were returned to 
service. If a patient had an episode date after the Find and Treat service had started, the Find 
and Treat database was checked for service involvement and cases were removed from the 
analysis appropriately. 
 
6810 cases were extracted, of which 219 (3.2%) were lost to follow up at one year. Of these, 
27 (12%) had a new episode of care in a London tuberculosis clinic. However, 2 of the new 
episodes were much later and had Find and Treat involvement. The 25 remaining cases had 
an average of 519 (range 29-2037) days between being lost to follow up to the new episode 
or notification. Of the 22 cases where a further outcome is known, 7 (30%) were lost to 
follow up within a year of their subsequent episode. 
 
An exponential model fitted the data well when the time to being lost to follow up was 
aggregated into time categories of 200 days (Figure A1-3). The best fitting model predicted 
that cases lost to follow up in the absence of Find and Treat re-engaged with treatment at a 
rate of 51.0% a year. 
 
Figure A1-3. Proportion of cases still engaged with treatment by time since treatment 
and best fitting exponential model to the data. 
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Clinical outcomes of untreated cases 
 
The prognosis of untreated tuberculosis cases was determined by the fate of cases detected in 
a 1975 survey in South India, in a region which, at the time, had no organised tuberculosis 
treatment
4
. Only results from the first survey were used (duration 1½ years), since in 
subsequent surveys cases were given isoniazid and advised to attend rural health institutions. 
The study found that 27.8% of cases identified during the survey were subsequently cured, 
30.2% died and 42.0% were still excreting bacilli. Mortality and recovery were assumed to be 
exponential processes to convert these into one year probabilities.  
 
Probability that cases referred to Find and Treat for loss to follow up return to service 
following Find and Treat involvement 
 
Between October 2007 and September 2010, 263 cases were referred to Find and Treat due to 
loss to follow up, of whom 180 had active pulmonary tuberculosis. Of these, 64 (36%) had 
completed treatment by 30 September 2010, 29 (16%) were still on treatment, 65 (36%) were 
still lost to follow up, 4 (2%) had died of tuberculosis-related causes and 18 (10%) had other 
final outcomes (transferred out of London, stopped treatment for clinical reasons or died of 
non-tuberculosis causes). Hence about 52% of cases could be regarded as having been 
returned to treatment by 30 September 2010 (final status returned to treatment or completed 
treatment). 
 
However, taking the proportion of cases who had been returned to treatment by 30 September 
2010 is misleading for two reasons. First, each case had been followed up for a different 
length of time (and cases who had been followed up by Find and Treat for longer presumably 
had a greater chance of being eventually returned to treatment). Secondly, there were 9 cases 
who had a treatment start date in London tuberculosis surveillance records after the date of 
Find and Treat referral, but a final outcome which was not that of having completed treatment 
or still being on treatment. These were presumably returned to treatment by Find and Treat 
but subsequently became lost to follow up again. 
 
To incorporate these considerations, Kaplan-Meier survival analysis was used to investigate 
the probability of remaining lost to follow up by follow-up time (i.e. the number of days since 
a case was first referred to Find and Treat). A “failure to survive” for the purpose of the 
analysis was being returned to treatment, defined as having a treatment start date in London 
tuberculosis surveillance records which came after the date of Find and Treat referral, or as 
having a final outcome of completing treatment or still being on treatment. Hence cases 
returned to treatment are included even if their final outcome was not being on or having 
completed treatment; the possibility that they may subsequently have been lost to follow up 
again (or had another adverse outcome) is considered separately below.  
 
The date of failure was defined as the first treatment start date in London tuberculosis 
surveillance records which came after the date of Find and Treat referral, or where the date 
was missing, the date at which treatment was completed. If both dates were missing, then the 
date of end of follow up (30 September 2010) was used as the date of failure. Hence the most 
conservative assumption was used where information was missing. Time to failure was then 
defined as the time between Find and Treat referral and failure date. Cases were censored at 
the end of their follow-up period if they were still lost to follow up at that time, and at their 
time of event if they were reported if they had other outcomes (death, transfer out or stopping 
treatment for clinical reasons). 
 
Figure A1-4 shows the cumulative survival probability (i.e. probability that a case will not 
have been returned to treatment yet) of the cohort of cases by time since their time of referral 
to Find and Treat. Even after 1000 days, the survival model suggests that about 51.0% of 
cases were still lost to follow up. Hence we assumed that this proportion of cases referred to 
Find and Treat due to loss to follow up would never be returned to treatment. For the 
remaining cases, the best fitting exponential model suggests they will be returned to treatment 
at the rate of about 81.7% a year. 
 
Figure A1-4. Cumulative survival probability (i.e. probability that a case will not have 
been returned to treatment yet) of cases referred to Find and Treat due to loss to follow 
up. 
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Probability that cases referred to Find and Treat for loss to follow up, who are returned to 
service, then become lost to follow up again 
 
To estimate the probability that cases returned to treatment by Find and Treat after being 
referred for loss to follow up were again lost, we identified 28 cases with a recorded date of 
starting treatment that occurred after the date of Find and Treat referral. Of these 28 cases, 13 
completed treatment, 9 were recorded as lost to follow up at the end of the follow-up period 
and 6 were still on treatment at the end of this period. 
 
Because of the small sample size and lack of information about the date at which cases 
became lost to follow up, it was not possible to fit a model to the time to loss to follow up in 
this group. Hence a simpler approach was taken. Assuming that each loss to follow up event 
occurred halfway between the time a case was placed on treatment and the end of the follow 
up period, the total number of days at which the 28 cases were at risk of being lost to follow 
up was 9475. Since 9 loss to follow up events occurred during this time, the probability that a 
case would be lost to follow up in a year was estimated to be 34.7%. It was assumed that 
these cases still had the opportunity to be returned to treatment at the rate that they did before 
(81.7% a year). 
 
Cases with active tuberculosis referred to Find and Treat for enhanced case management 
 
To analyse the outcomes of the 188 tuberculosis cases referred to Find and Treat for case 
management support, an exponential model was fitted to the proportion of cases who were 
still on treatment, had completed treatment, were lost to follow up and had a different 
outcome, by time since their referral to Find and Treat (aggregated into 50-day categories). 
Time was not allocated for the period during which no case can complete treatment as this 
was not necessary to achieve a good fit, presumably because most of these cases had already 
been on treatment when they were first engaged by the Find and Treat service.  The annual 
rate of completing treatment, dying of tuberculosis, being lost to follow up and having a 
different outcome in the best fitting model are 61.2%, 3.3%, 2.6% and 11.3% respectively 
(Figure A1-5). If the cases are not managed by Find and Treat, they are assumed to have a 
one-year probability of loss to follow up of 34.7%, the same as the risk of being lost again in 
the group of cases referred to Find and Treat for loss to follow up who subsequently re-
engage with treatment. 
Figure A1-5. Outcomes of the 188 active tuberculosis cases referred to Find and Treat 
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Appendix 2: Health states over time for cases engaged with Find and Treat, and 
hypothetical equivalent cases without Find and Treat 
 
Different health states over time for the cases detected by the mobile screening unit in a 
single year that have had active tuberculosis symptoms for at most 131 days before 
being screened. 
  
 
 
 
Different health states over time for the cases detected by the mobile screening unit in a 
single year that have had active tuberculosis symptoms for more than 131 days before 
being screened (and hence were assumed to be undetected by passive case finding). 
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Different health states over time for the cases detected by the mobile screening unit in a 
single year that did not have symptoms on detection. 
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managed by Find and Treat. 
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Different health states over time for the cases in a single year who were referred for loss 
to follow up and subsequently found by Find and Treat. 
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